Dynavax Technologies Corporation DYF1.F Stock
Dynavax Technologies Corporation Price Chart
Dynavax Technologies Corporation DYF1.F Financial and Trading Overview
| Dynavax Technologies Corporation stock price | 10.34 EUR |
| Previous Close | 11.42 EUR |
| Open | 11.42 EUR |
| Bid | 11.61 EUR x 24800 |
| Ask | 0 EUR x 23900 |
| Day's Range | 11.6 - 11.6 EUR |
| 52 Week Range | 8.66 - 16.91 EUR |
| Volume | 600 EUR |
| Avg. Volume | 25 EUR |
| Market Cap | 1.53B EUR |
| Beta (5Y Monthly) | 1.484507 |
| PE Ratio (TTM) | 7.529221 |
| EPS (TTM) | 0.06 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 21.75 EUR |
DYF1.F Valuation Measures
| Enterprise Value | 1.07B EUR |
| Trailing P/E | 7.529221 |
| Forward P/E | 7.5784316 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 2.3306692 |
| Price/Book (mrq) | 2.642434 |
| Enterprise Value/Revenue | 1.634 |
| Enterprise Value/EBITDA | 4.008 |
Trading Information
Dynavax Technologies Corporation Stock Price History
| Beta (5Y Monthly) | 1.484507 |
| 52-Week Change | 22.08% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 16.91 EUR |
| 52 Week Low | 8.66 EUR |
| 50-Day Moving Average | 9.81 EUR |
| 200-Day Moving Average | 10.42 EUR |
DYF1.F Share Statistics
| Avg. Volume (3 month) | 25 EUR |
| Avg. Daily Volume (10-Days) | 60 EUR |
| Shares Outstanding | 128.49M |
| Float | 121.64M |
| Short Ratio | N/A |
| % Held by Insiders | 0.23% |
| % Held by Institutions | 92.94% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 35.99% |
| Operating Margin (ttm) | 40.18% |
| Gross Margin | 61.60% |
| EBITDA Margin | 40.77% |
Management Effectiveness
| Return on Assets (ttm) | 16.64% |
| Return on Equity (ttm) | 55.44% |
Income Statement
| Revenue (ttm) | 655.62M EUR |
| Revenue Per Share (ttm) | 5.15 EUR |
| Quarterly Revenue Growth (yoy) | -58.79% |
| Gross Profit (ttm) | 448.22M EUR |
| EBITDA | 267.31M EUR |
| Net Income Avi to Common (ttm) | 235.81M EUR |
| Diluted EPS (ttm) | 1.54 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 651.96M EUR |
| Total Cash Per Share (mrq) | 5.07 EUR |
| Total Debt (mrq) | 257.82M EUR |
| Total Debt/Equity (mrq) | 45.73 EUR |
| Current Ratio (mrq) | 9.071 |
| Book Value Per Share (mrq) | 4.388 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 140.78M EUR |
| Levered Free Cash Flow (ttm) | 78.86M EUR |
Profile of Dynavax Technologies Corporation
| Country | Germany |
| State | CA |
| City | EmeryVille |
| Address | 2100 Powell Street |
| ZIP | 94608 |
| Phone | 510 848 5100 |
| Website | https://www.dynavax.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 351 |
Dynavax Technologies Corporation, a commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States. It markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. The company also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a collaboration agreement with Valneva Scotland Limited; Zhejiang Clover Biopharmaceuticals, Inc.; Clover Biopharmaceuticals (Hong Kong) Co., Limited; Biological E. Limited; PT Bio Farma; Medigen Vaccine Biologics; and Serum Institute of India Pvt. Ltd. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. Dynavax Technologies Corporation was incorporated in 1996 and is headquartered in Emeryville, California.
Q&A For Dynavax Technologies Corporation Stock
What is a current DYF1.F stock price?
Dynavax Technologies Corporation DYF1.F stock price today per share is 10.34 EUR.
How to purchase Dynavax Technologies Corporation stock?
You can buy DYF1.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Dynavax Technologies Corporation?
The stock symbol or ticker of Dynavax Technologies Corporation is DYF1.F.
Which industry does the Dynavax Technologies Corporation company belong to?
The Dynavax Technologies Corporation industry is Drug Manufacturers-Specialty & Generic.
How many shares does Dynavax Technologies Corporation have in circulation?
The max supply of Dynavax Technologies Corporation shares is 136.6M.
What is Dynavax Technologies Corporation Price to Earnings Ratio (PE Ratio)?
Dynavax Technologies Corporation PE Ratio is 172.33334000 now.
What was Dynavax Technologies Corporation earnings per share over the trailing 12 months (TTM)?
Dynavax Technologies Corporation EPS is 0.06 EUR over the trailing 12 months.
Which sector does the Dynavax Technologies Corporation company belong to?
The Dynavax Technologies Corporation sector is Healthcare.